USX:AMLX - Amylyx Pharmaceuticals Inc

Amylyx Pharmaceuticals Inc
Sector: Health Care, Industry: Biotechnology

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts
• Charts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized

Show %	2019	2020	2021	2022	2023	Graph
Total Revenue	[friend]	[friend]	0 -	22.23M -	380.79M 1612.9%
Cost of Revenue	[friend]	[friend]	0 -	2.99M -	25.44M 750.0%
Gross Profit	[friend]	[friend]	0 -	19.24M -	355.35M 1747.2%
Total Expenses	[friend]	[friend]	82.69M 112.0%	223.57M 170.4%	341.98M 53.0%
Operating Expense	[friend]	[friend]	82.69M 112.0%	220.58M 166.8%	316.54M 43.5%
Operating Income	[friend]	[friend]	-82.69M -	-201.34M -	38.8M -
Net Income (Cont Operations)	[friend]	[friend]	-87.93M -	-198.38M -	49.27M -
Net Income	[friend]	[friend]	-87.93M -	-198.38M -	49.27M -
Basic EPS	[friend]	[friend]	-1.592 -	-3.39 -	0.73 -
Diluted EPS	[friend]	[friend]	-1.592 -	-3.39 -	0.7 -